Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.85 USD | +0.92% |
|
-12.96% | -30.73% |
28/06 | Needham Trims Price Target on Rocket Pharmaceuticals to $52 From $53, Maintains Buy Rating | MT |
28/06 | Rocket Pharmaceuticals Says FDA Seeks More Information on Kresladi | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.73% | 187.56Cr | |
+16.99% | 12TCr | |
+18.02% | 11TCr | |
+19.62% | 2.57TCr | |
-25.78% | 1.9TCr | |
-20.21% | 1.58TCr | |
-19.30% | 1.53TCr | |
-47.37% | 1.49TCr | |
+60.96% | 1.48TCr | |
+4.91% | 1.41TCr |
- Stock Market
- Equities
- RCKT Stock
- News Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals Says FDA Seeks More Information on Kresladi